Assignee
GUGLIELMOTTI ANGELO
IT·8 granted patents·1 pending application·45 citations·filing 2007–2012
Top patents by PatentIndex Score
9 records- 0189US8835481B21-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40GUGLIELMOTTI ANGELO·Filed 2009·Granted Sep 16, 2014·13 cites·22 claims
- 0289US8198310B2Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levelsGUGLIELMOTTI ANGELO·Filed 2007·Granted Jun 12, 2012·15 cites·12 claims
- 0383US8461194B21-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40GUGLIELMOTTI ANGELO·Filed 2009·Granted Jun 11, 2013·6 cites·17 claims
- 0482US8314099B21-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1GUGLIELMOTTI ANGELO·Filed 2009·Granted Nov 20, 2012·5 cites·24 claims
- 0580US8283348B21-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40GUGLIELMOTTI ANGELO·Filed 2011·Granted Oct 9, 2012·4 cites·8 claims
- 0674US8569297B21-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1GUGLIELMOTTI ANGELO·Filed 2012·Granted Oct 29, 2013·2 cites·28 claims
- 0752US8846745B2Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levelsGUGLIELMOTTI ANGELO·Filed 2012·Granted Sep 30, 2014·0 cites·6 claims
- 0839US9492542B2Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseasesGUGLIELMOTTI ANGELO·Filed 2010·Granted Nov 15, 2016·0 cites·10 claims
- 0935US2012302618A1Use of benzydamine in the treatment of p40-dependent diseasesGUGLIELMOTTI ANGELO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GUGLIELMOTTI ANGELO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →